Align Technology Inc Valuation – February 2019 $ALGN
Company Profile (excerpt from Reuters): Align Technology, Inc., incorporated on April 3, 1997, designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services. iTero scanner is used by dental professionals, and labs and services for restorative and orthodontic digital procedures, as well as Invisalign digital impression submission.
Downloadable PDF version of this valuation:
ModernGraham Valuation of ALGN – February 2019
Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?
What kind of Intelligent Investor are you?
| Defensive Investor; must pass 6 out of the following 7 tests. | ||||
| 1. Adequate Size of the Enterprise | Market Cap > $2Bil | $19,185,761,689 | Pass | |
| 2. Sufficiently Strong Financial Condition | Current Ratio > 2 | 1.88 | Fail | |
| 3. Earnings Stability | Positive EPS for 10 years prior | Pass | ||
| 4. Dividend Record | Dividend Payments for 10 years prior | Fail | ||
| 5. Earnings Growth | Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end | 391.57% | Pass | |
| 6. Moderate PEmg Ratio | PEmg < 20 | 63.09 | Fail | |
| 7. Moderate Price to Assets | PB Ratio < 2.5 OR PB*PEmg < 50 | 15.50 | Fail | |
| Enterprising Investor; must pass 4 out of the following 5 tests, or be suitable for the Defensive Investor. | ||||
| 1. Sufficiently Strong Financial Condition | Current Ratio > 1.5 | 1.88 | Pass | |
| 2. Sufficiently Strong Financial Condition | Debt to NCA < 1.1 | 0.00 | Pass | |
| 3. Earnings Stability | Positive EPS for 5 years prior | Pass | ||
| 4. Dividend Record | Currently Pays Dividend | Fail | ||
| 5. Earnings Growth | EPSmg greater than 5 years ago | Pass | ||
Stage 2: Determination of Intrinsic Value
| EPSmg | $3.80 |
| MG Growth Estimate | 15.00% |
| MG Value | $146.43 |
| Opinion | Overvalued |
| MG Grade | C- |
| MG Value based on 3% Growth | $55.15 |
| MG Value based on 0% Growth | $32.33 |
| Market Implied Growth Rate | 27.29% |
| Current Price | $239.94 |
| % of Intrinsic Value | 163.86% |
Align Technology, Inc. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, poor dividend history, and the high PEmg and PB ratios. The Enterprising Investor is only concerned with the lack of dividends. As a result, all Enterprising Investors following the ModernGraham approach should feel comfortable proceeding with the analysis.
As for a valuation, the company appears to be Overvalued after growing its EPSmg (normalized earnings) from $1.37 in 2015 to an estimated $3.8 for 2019. This level of demonstrated earnings growth does not support the market’s implied estimate of 27.29% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on the Benjamin Graham value investing formula, returns an estimate of intrinsic value below the price.
At the time of valuation, further research into Align Technology, Inc. revealed the company was trading above its Graham Number of $39.78. The company does not pay a dividend. Its PEmg (price over earnings per share – ModernGraham) was 63.09, which was above the industry average of 51.18. Finally, the company was trading above its Net Current Asset Value (NCAV) of $6.21.
Align Technology, Inc. receives an average overall rating in the ModernGraham grading system, scoring a C-.
Stage 3: Information for Further Research
| Net Current Asset Value (NCAV) | $6.21 |
| Graham Number | $39.78 |
| PEmg | 63.09 |
| Current Ratio | 1.88 |
| PB Ratio | 15.50 |
| Current Dividend | $0.00 |
| Dividend Yield | 0.00% |
| Number of Consecutive Years of Dividend Growth | 0 |
Useful Links:
| ModernGraham tagged articles | Morningstar |
| Google Finance | MSN Money |
| Yahoo Finance | Seeking Alpha |
| GuruFocus | SEC Filings |
Most Recent Balance Sheet Figures
| Balance Sheet Information | 12/1/2018 |
| Total Current Assets | $1,302,479,000 |
| Total Current Liabilities | $692,073,000 |
| Long-Term Debt | $0 |
| Total Assets | $2,052,458,000 |
| Intangible Assets | $81,949,000 |
| Total Liabilities | $799,567,000 |
| Shares Outstanding (Diluted Average) | 80,943,000 |
Earnings Per Share History
| EPS History | |
| Next Fiscal Year Estimate | $4.49 |
| Dec2018 | $4.92 |
| Dec2017 | $2.83 |
| Dec2016 | $2.33 |
| Dec2015 | $1.77 |
| Dec2014 | $1.77 |
| Dec2013 | $0.78 |
| Dec2012 | $0.71 |
| Dec2011 | $0.83 |
| Dec2010 | $0.95 |
| Dec2009 | -$0.45 |
| Dec2008 | $1.18 |
| Dec2007 | $0.50 |
| Dec2006 | -$0.55 |
| Dec2005 | $0.02 |
| Dec2004 | $0.14 |
| Dec2003 | -$0.35 |
| Dec2002 | -$1.52 |
| Dec2001 | -$2.61 |
| Dec2000 | -$25.64 |
| Dec1999 | -$3.65 |
Earnings Per Share – ModernGraham History
| EPSmg History | |
| Next Fiscal Year Estimate | $3.80 |
| Dec2018 | $3.21 |
| Dec2017 | $2.21 |
| Dec2016 | $1.75 |
| Dec2015 | $1.37 |
| Dec2014 | $1.11 |
| Dec2013 | $0.71 |
| Dec2012 | $0.67 |
| Dec2011 | $0.63 |
| Dec2010 | $0.46 |
| Dec2009 | $0.19 |
| Dec2008 | $0.43 |
| Dec2007 | $0.02 |
| Dec2006 | -$0.30 |
| Dec2005 | -$0.40 |
| Dec2004 | -$2.41 |
| Dec2003 | -$4.71 |
Recommended Reading:
Other ModernGraham posts about the company
Other ModernGraham posts about related companies
Disclaimer:
The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  See my current holdings here.  This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions.  ModernGraham is not affiliated with the company in any manner.  Please be sure to review our detailed disclaimer.
